Details

Autor(en) / Beteiligte

• Stipp, David

Titel

13 biotech IPOs to watch for

Ist Teil von

• Fortune, 2000-04, Vol.141 (7), p.158

Ort / Verlag

New York: Time Incorporated

Erscheinungsjahr

2000

Quelle

EBSCOhost Business Source Ultimate

Beschreibungen/Notizen

• Initial public offerings are busting out in the biotechnology industry like desert flowers after rain. The burst was triggered late last year by investor lust for newly shared issues of 4 companies: Tularik, Maxygen, Caliper Technologies, and Symyx. With so many offerings on the way, investors are likely to be glutted with new biotech shares before long. The genomics bubble may further deflate, dragging down the whole sector.